fbpx

The Dangers of Bladder Control Medications

Posted on: 12th Mar, 2021

dr-sasse-reno-continence-center-dangers-bladder-medications

The most recent guidance from the American Urogynecologic Society has called out the dangers of anti-cholinergic medications used to treat bladder incontinence. Describing the class of medications which includes the most widely prescribed names such as Ditropan, Oxybutynin, Detrol, and Vesicare, the guideline paper describes that “Recently, additional concerns have emerged regarding prolonged use of anticholinergic medications and the associated risk of cognitive impairment, dementia, and Alzheimer disease in the general population. Given the available evidence, which has shown significant associations between anticholinergic medication use and increased risk of cognitive impairment and dementia, providers should counsel on the associated risks, prescribe the lowest effective dose, and consider alternative medications in patients at risk.”

The new guidelines mirror those of other organizations, including AARP, the American Association of Retired Persons which recommended these medications not be prescribed for individuals over 50 years old. Since most of the patients who are suffering with the problems of incontinence are over 50 years old, the concerns about degradation of memory and cognitive function among seniors is especially relevant.

sasse-surgical-reno

Better Treatments are Available

At the Continence Center, our policy has been to avoid anticholinergic medications in all patients over 50 years old based on the above guidelines and the overall poor success rate of the medications. We instead emphasize pelvic floor exercise therapy combined with sacral neuromodulation, the most effective and lowest risk, evidence-based solution with an over 90% success rate. The advantages of a solution that involves natural exercises, advanced technology, medication avoidance, and a non-surgical minimally invasive neuromodulation that restores a person’s own muscles and sphincters cannot be overstated.

Similar Recent Posts

  • What Research tells us about Obesity, Bariatric Surgery, and Cognitive Function

    • nevada-surgical-cognition-obesity

      Alexander Ayzengart, MD, MPH, FACS, specializes in advanced laparoscopic, metabolic, and bariatric surgery. Before joining Nevada Surgical, Dr. Ayzengart provided his expertise in weight loss surgery, gastroesophageal disease, anti-reflux surgery, and abdominal and inguinal hernia surgery at the University of Florida Health Bariatric Surgery Center. As a new member of the Nevada Surgical team, he’s bringing his expertise Read More…

  • A Post on Sixty & Me: My Bladder Sling Failed – Now What?

    • sasse-surgical-reno-patient-review-sacral-neuromodulation-for-incontinence

      As a regular contributor to Sixty & Me, Dr. Sasse shares commentary on the effects of both incontinence and obesity on seniors, plus the most effective and appropriate treatments. One relevant topic? A failing bladder sling. Read on for the highlights, or check out the post in full. From the Post “The bladder sling is Read More…

  • Perspective on the Newly Approved Diabetes Drug for Weight Loss

    • diabetes-drug-for-weight-loss-nevada-surgical

      A recent headline on CNN excitedly notes that “overweight people lost 35 to 52 pounds on newly approved diabetes drug, study says.” A weekly dose of a medication, recently approved by the FDA, used to treat type 2 diabetes may also help adults without the condition lose weight. Here’s what the study revealed, plus a Read More…

Address
Nevada Surgical
75 Pringle Way
Suite 804

Reno, NV 89502
Minimally invasive weight loss surgery experts.info@sassesurgical.com(775) 829-7999
Phone
Office Hours
Monday
7:30 am - 5:00 pm
Tuesday
7:30 am - 5:00 pm
Wednesday
7:30 am - 5:00 pm
Thursday
7:30 am - 5:00 pm
Friday
7:30 am - 3:00 pm
Saturday
Closed
Sunday
Closed